BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9491519)

  • 1. Radiation therapy for incompletely resected canine mast cell tumors.
    LaDue T; Price GS; Dodge R; Page RL; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
    Chaffin K; Thrall DE
    Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
    Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
    J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for canine mast cell tumors.
    Mayer MN
    Can Vet J; 2006 Mar; 47(3):263-5. PubMed ID: 16604985
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
    Hahn KA; King GK; Carreras JK
    J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).
    Frimberger AE; Moore AS; LaRue SM; Gliatto JM; Bengtson AE
    J Am Anim Hosp Assoc; 1997; 33(4):320-4. PubMed ID: 9204467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs.
    Turrel JM; Kitchell BE; Miller LM; Théon A
    J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
    Weisse C; Shofer FS; Sorenmo K
    J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.
    al-Sarraf R; Mauldin GN; Patnaik AK; Meleo KA
    J Vet Intern Med; 1996; 10(6):376-8. PubMed ID: 8947870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating the locoregional lymph nodes with radiation and/or surgery significantly improves outcome in dogs with high-grade mast cell tumours.
    Mendez SE; Drobatz KJ; Duda LE; White P; Kubicek L; Sorenmo KU
    Vet Comp Oncol; 2020 Jun; 18(2):239-246. PubMed ID: 31509648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
    J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
    Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
    J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
    Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
    J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
    Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
    J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010).
    Baginski H; Davis G; Bastian RP
    J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy and surgery for fibrosarcoma in 33 cats.
    Cronin K; Page RL; Spodnick G; Dodge R; Hardie EN; Price GS; Ruslander D; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):51-6. PubMed ID: 9491518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
    Cahalane AK; Payne S; Barber LG; Duda LE; Henry CJ; Mauldin GE; Frimberger AE; Cotter SM; Moore AS
    J Am Vet Med Assoc; 2004 Aug; 225(3):401-8. PubMed ID: 15328716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.